Home » Stocks » ILAC

Innovatus Life Sciences Acquisition Corp. (ILAC)

Innovatus Life Sciences Acquisition will go public soon, but the exact IPO date is still unknown.
Stock Price: $10.00
Confirmed IPO price
Market Cap 224.60M
Revenue (ttm) n/a
Net Income (ttm) n/a
Shares Out 22.46M
EPS (ttm) n/a
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a
Trading Day n/a
Last Price n/a
Previous Close n/a
Change ($) n/a
Change (%) n/a
Day's Open n/a
Day's Range n/a
Day's Volume n/a
52-Week Range n/a

News

Innovatus Life Sciences Acquisition Corp. has filed to go public with an IPO on the NASDAQ.

2 weeks ago - SEC

About ILAC

Innovatus Life Sciences Acquisition Corp. is a blank check company whose business purpose is to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. We intend to initially focus our search on identifying a prospective target business in the life sciences sector. Our sponsor is an affiliate of Innovatus Capital Partners, LLC, a boutique private equity firm with 27 professionals focused on creating value in special situations, growth equity, emergin... [Read more...]

Industry
Blank Checks / SPAC
IPO Date
Pending
CEO
David Schiff
Country
United States
Stock Exchange
NASDAQ
Ticker Symbol
ILAC
Full Company Profile